Lotus Eye Hosp Peer Comparison

NSE: LOTUSEYE | BSE: 532998

₹107.13

₹-6.80 (-5.97%)

As on 12-Oct-2026IST

Market cap

₹223 Cr

Revenue (TTM)

₹57 Cr

P/E Ratio

1484.9

P/B Ratio

3.7

Div. Yield

0 %

Edit

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Market cap (₹ Cr)	223	112	36	30	26
Revenue (₹ Cr)	57	26	17	24	0
Net Profit (₹ Cr)	0.15	-0.45	1.93	-3.62	-8.72
Net Margin (%)	0.26	-1.72	10.69	-15.36	-17,442.00
RoE (%)	0.26	-3.41	5.30	--	-60.02
Price to Earnings	1,484.86	--	18.49	--	--
Price-To-Book	3.67	9.22	1.05	-11.34	2.27

Income Statement (₹ Cr)

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Operating Revenue	53.71	22.00	16.55	29.84	0.02
Total Income	54.89	22.39	24.55	31.18	0.05
Total Expenditure	50.16	18.47	14.69	29.92	8.73
EBITDA	3.55	3.52	1.86	-0.08	-8.71
Depreciation	3.75	1.49	0.61	0.50	0.00
EBIT	-0.20	2.03	1.25	-0.58	-8.72
Interest	1.03	0.35	0.10	0.99	0.00
Other Income	1.18	0.39	8.00	1.35	0.03
Exceptional Items	0.00	--	--	--	--
Profit before Tax	-0.05	2.02	9.14	-0.22	-8.69
Provision for Tax	-0.13	--	1.40	-0.04	--
Profit after Tax	0.08	2.02	7.74	-0.19	-8.69

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Shareholder's Funds	60.14	12.17	38.52	1.30	11.75
Minority Interest	--	--	--	--	--
Non-Current Liabilities	12.92	2.92	0.66	10.49	0.09
Current Liabilities	9.34	2.37	2.44	10.38	2.54
Total Liabilities	82.60	17.46	41.62	22.17	14.38

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Non-Current Assets	71.03	12.10	37.58	8.39	11.84
Current Assets	11.37	5.36	4.04	13.78	2.54
Total Assets	82.60	17.46	41.62	22.17	14.38
Total Debt*	12.10	1.21	1.78	10.52	1.66
Net Current Assets	2.03	2.99	1.59	3.39	0.01
Contingent Liabilities	0.99	1.12	0.09	0.03	--

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Cash From Operating Activities	3.02	1.83	1.81	1.47	-4.26
Cash Flow from Investing Activities	-12.37	0.12	-1.23	-0.52	3.26
Cash from Financing Activities	9.03	-0.99	-0.62	-0.24	2.63
Net Cash Inflow / Outflow	-0.32	0.95	-0.03	0.71	1.63

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
ROCE (%)	1.47	19.27	23.83	6.58	-62.45
ROE (%)	0.13	18.13	20.73	-12.79	-73.22
ROA (%)	0.11	12.57	18.98	-0.89	-58.00
EBIT Margin (%)	8.81	17.79	59.58	4.24	-47,884.92
Net Margin (%)	0.15	9.03	31.53	-0.60	-17,511.30
Cash Profit Margin (%)	7.13	15.98	50.48	1.06	0.00

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Revenue Growth (%)	8.38	66.60	-1.99	9.48	--
EBIT Growth (%)	-2.68	611.07	51.11	607.46	-3,282.58
Net Profit Growth (%)	-89.12	175.69	53.75	88.92	-3,247.46
EPS Growth (%)	-89.11	175.69	53.75	88.92	-1,765.31
Book Value Growth (%)	0.23	19.94	6.59	-19.64	-1.83

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Price / Earnings	2,618.86	43.37	7.06	0.00	0.00
Price / Book Value	3.50	7.21	1.42	15.72	3.07
Dividend Yield (%)	0.00	0.00	2.15	0.00	0.00
EV/EBITDA	46.31	22.18	5.48	22.85	-4.16
Market Cap (₹ Cr)	210.77	87.73	54.63	20.42	36.08

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Debt to Equity	0.20	0.10	0.05	8.10	0.14
Short term debt to equity ratio	--	--	0.05	0.31	0.14
Current Ratio	1.22	2.26	1.65	1.33	1.00
Quick Ratio	0.81	2.05	1.56	1.24	1.00
Interest Coverage	0.95	6.82	88.23	0.78	-7,532.35

	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare	Samsrita Labs
Debtors to sales (%)	2.25	10.69	2.58	29.37	108.10
Asset Turnover	0.71	1.37	0.41	1.43	0.00
Receivable days	8.60	38.11	6.31	96.98	0.00
Inventory Days	26.04	7.95	15.24	8.69	0.00
Payable days	72.50	72.32	0.00	251.51	582.01
Cash Conversion Cycle	-37.86	-26.26	21.54	-145.84	-582.01

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.